CD274 and hepatocellular carcinoma: For instance, in the study of PD-1/PD-L1 inhibitors in hepatocellular carcinoma (HCC), organoids should retain at least the epithelial cells (malignant cells ± normal hepatocytes), T cells, and macrophages at physiologically relevant ratios.